Back to search

Article

Leucoverdazyls as novel potent inhibitors of enterovirus replication

2024-04-11

Abstract excerpt

Enteroviruses (EV) are important pathogens causing human disease with various clinical manifestations. To date, treatment of enteroviral infections is mainly supportive since no vaccination or antiviral drugs are approved for their prevention or treatment. Here, we describe the antiviral properties and mechanisms of action of leucoverdazyls - novel heterocyclic compounds with antioxidant potential. The lead compou...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ef2742fc-d76c-5752-ab7d-7ce41c0316c9
DOI
10.20944/preprints202404.0785.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Leucoverdazyls as novel potent inhibitors of enterovirus replicationDOI 10.20944/preprints202404.0785.v1
Select a neighboring publication to make it the new centre.